Senate Judiciary Committee holds hearing on CREATES Act
The Senate Judiciary Committee today held a hearing on the Creating and Restoring Equal Access to Equivalent Samples Act, AHA-supported legislation that targets anticompetitive behaviors used to block and delay entry of generic drugs. The bipartisan legislation would allow a generic drug manufacturer facing one of these delay tactics to bring an action in federal court for injunctive relief and allow a judge to award damages to deter future delaying conduct. Testifying at the hearing were representatives from the Edwin Meese III Center for Legal and Judicial Studies; Institute for Innovation Law; Covington & Burling LLP; Amneal Pharmaceuticals; Consumers Union; and American College of Physicians.
Related News Articles
Headline
The Senate Committee on Health, Education, Labor and Pensions today held the second in a series of hearings on the cost of prescription drugs. “We…
Headline
In a letter this week, the AHA again urged the Centers for Medicare & Medicaid Services to take specific actions to address and prevent the serious…
Headline
The New Jersey Hospital Association yesterday named as its next president and CEO Cathleen Bennett, an attorney who currently serves as commissioner of the New…
Headline
The Senate will not vote this week on a proposal by Sens. Lindsey Graham, R-S.C., Bill Cassidy, R-La., Dean Heller, (R-Nev., and Ron Johnson, R-Wis., to repeal…
Headline
The AHA today voiced opposition to a proposal introduced last week by Sens. Lindsey Graham (R-SC), Bill Cassidy (R-LA), Dean Heller (R-NV) and Ron Johnson (R-…
Headline
The Senate Finance Committee today held a hearing on issues impacting health care costs and coverage. Witnesses included former Centers for Medicare &…